INFUSYSTEM HOLDINGS, INC Deferred Tax Assets, Operating Loss Carryforwards
INFUSYSTEM HOLDINGS, INC (INFU) had Deferred Tax Assets, Operating Loss Carryforwards of $1.39 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-27
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $1.39M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $3.43M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $6.40M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $8.68M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $1.39M 10-K · filed 2026-02-27 |
| 2024-12-31 | $3.43M 10-K · filed 2026-02-27 |
| 2023-12-31 | $6.40M 10-K · filed 2025-03-11 |
| 2022-12-31 | $8.68M 10-K · filed 2024-04-10 |
| 2019-12-31 | $9.40M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |